BOSTON – March 7, 2025 – Global law firm Greenberg Traurig, LLP’s Life Sciences & Medical Technology Group was named a finalist for three 2025 Life Sciences Patent Network (LSPN) Awards, recognizing the firm’s excellence and leadership in life sciences intellectual property (IP).
Greenberg Traurig is a finalist in the following categories:
- Life Sciences Patent Strategy Firm of the Year
- Life Sciences Prosecution Firm of the Year
- Patent Prosecutor of the Year – David Dykeman
In a joint statement, Co-Chairs of Greenberg Traurig’s Global Life Sciences and Medical Technology Group David J. Dykeman and Wayne H. Elowe said, “These nominations reflect the strength of Greenberg Traurig’s life sciences team and its strategic patent counsel, our deep industry knowledge, and our dedication to helping life sciences companies protect groundbreaking innovations. We are honored to be recognized among the leading firms shaping the future of life sciences IP.”
Organized by Life Sciences Intellectual Property Review, the LSPN Awards USA 2025 recognizes outstanding achievements in pharmaceutical and biotech patent protection. These awards celebrate the organizations that are pushing boundaries, delivering exceptional results, and shaping the future of life sciences IP. Winners will be announced at an awards ceremony May 6 at the Colonnade Hotel in Boston.